Artículos (12) Publicaciones en las que ha participado algún/a investigador/a

1986

  1. Bioavailability of amoxapine in experimental animals

    Bollettino Chimico Farmaceutico, Vol. 125, Núm. 8, pp. 307-311

  2. Ceforanide pharmacokinetics in haemodialysis: The effect of ultrafiltration

    Biopharmaceutics & Drug Disposition, Vol. 7, Núm. 4, pp. 335-346

  3. ESTUDIO 'IN VITRO' DE ALGUNOS FACTORES QUE MODIFICAN LA ACTIVIDAD ANTIBACTERIANA DE LA DIBECACINA

    Infectologika, Vol. 7, Núm. 4, pp. 7-10

  4. Effect of Sodium Valproate on Phenobarbital Serum Levels in Children and Adults

    Therapeutic Drug Monitoring, Vol. 8, Núm. 4, pp. 416-420

  5. FACTORES QUE MODIFICAN LA INTERACCION HAPA-B/CARBENICILINA

    Infectologika, Vol. 7, Núm. 4, pp. 39-42

  6. INFLUENCIA DE AGENTES TENSIOACTIVOS EN LA ABSORCION GASTROINTESTINAL DE DIBECACINA

    Ciencia e Industria Farmaceutica, Vol. 5, Núm. 11, pp. 354-358

  7. In-vitro interaction between dibekacin and penicillins

    Journal of Antimicrobial Chemotherapy, Vol. 17, Núm. 1, pp. 83-89

  8. Isolation and identification of the N-oxide metabolite of picobenzide in human urine

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 11, Núm. 1, pp. 23-27

  9. Pleural fluid levels of cefoxitin in patients with renal impairment

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 24, Núm. 9, pp. 485-489

  10. The biotransformation kinetics of Ketamine "in vitro" in rabbit liver and lung microsome fractions

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 11, Núm. 1, pp. 9-16

  11. The phenfluramine-montmorillonite complex: adsorption and desorption

    Pharmaceutica Acta Helvetiae, Vol. 61, Núm. 9, pp. 267-272

  12. Urinary and biliary excretion kinetics of ketamine and its metabolites in the rabbit.

    Bollettino Chimico Farmaceutico, Vol. 125, Núm. 9, pp. 357-361